迟发性系统性红斑狼疮合并癫痫及弥漫性 肺泡出血的临床分析
Clinical Analysis of Late-Onset Systemic Lupus Erythematosus Complicated by Epilepsy and Diffuse Alveolar Hemorrhage
DOI: 10.12677/acm.2026.1631040, PDF,    科研立项经费支持
作者: 王屈鑫茹, 段玉婷:青岛大学附属医院老年医学科,山东 青岛;青岛大学医学院,山东 青岛;胡 松, 毛拥军*:青岛大学附属医院老年医学科,山东 青岛
关键词: 迟发性系统性红斑狼疮神经精神性狼疮癫痫弥漫性肺泡出血Late-Onset Systemic Lupus Erythematosus Neuropsychiatric Systemic Lupus Erythematosus Epilepsy Diffuse Alveolar Hemorrhage
摘要: 迟发性系统性红斑狼疮(late-onset systemic lupus erythematosus, Lo-SLE)是指在50岁后诊断出系统性红斑狼疮(systemic lupus erythematosus, SLE)的一种罕见的自身免疫性疾病,Lo-SLE起病隐匿、临床表现不典型,易被感染或其他老年常见疾病掩盖。我们回顾性分析了一例我院收治的85岁高龄老人初诊为SLE并发癫痫及弥漫性肺泡出血(diffuse alveolar hemorrhage, DAH)的病例。患者早期以感染性疾病为主要诊断方向,经抗感染治疗效果欠佳后,完善自身免疫学检查,明确诊断为SLE。激素治疗过程中患者出现新发癫痫发作,并迅速进展为难治性癫痫持续状态(refractory status epilepticus, RSE),随后病情急剧恶化,突发大量咯血及呼吸循环衰竭,临床高度考虑暴发性DAH,最终抢救无效死亡。因此,对老年不明原因多系统受累患者,应及早进行自身免疫性疾病筛查,一旦出现神经精神症状或危及生命的并发症,应在严格评估感染风险的前提下,尽早考虑强化免疫抑制治疗及多学科协作干预,以改善预后。
Abstract: Late-onset systemic lupus erythematosus (Lo-SLE) refers to a rare autoimmune disease diagnosed after age 50. Lo-SLE has an insidious onset with atypical clinical manifestations, often masked by infections or other common geriatric conditions. We retrospectively analyzed a case of an 85-year-old patient admitted to our hospital who developed epilepsy and diffuse alveolar hemorrhage (DAH) following an initial SLE diagnosis. The patient was initially managed for infectious disease, but after inadequate response to antimicrobial therapy, comprehensive immunological testing confirmed SLE. During corticosteroid therapy, the patient developed new-onset seizures that rapidly progressed to refractory status epilepticus (RSE). The condition then deteriorated precipitously, manifesting as massive hemoptysis and respiratory-circulatory failure. Clinically, fulminant DAH was strongly suspected, and the patient ultimately succumbed despite resuscitative efforts. Therefore, for elderly patients with unexplained multisystem involvement, early screening for autoimmune diseases is essential. Upon the emergence of neuropsychiatric symptoms or life-threatening complications, intensive immunosuppressive therapy and multidisciplinary collaborative intervention should be considered promptly, while rigorously assessing infection risks, to improve prognosis.
文章引用:王屈鑫茹, 段玉婷, 胡松, 毛拥军. 迟发性系统性红斑狼疮合并癫痫及弥漫性 肺泡出血的临床分析[J]. 临床医学进展, 2026, 16(3): 2421-2428. https://doi.org/10.12677/acm.2026.1631040

参考文献

[1] Boddaert, J., Huong, D.L.T., Amoura, Z., Wechsler, B., Godeau, P. and Piette, J. (2004) Late-Onset Systemic Lupus Erythematosus: A Personal Series of 47 Patients and Pooled Analysis of 714 Cases in the Literature. Medicine, 83, 348-359. [Google Scholar] [CrossRef] [PubMed]
[2] Assan, F., Seror, R., Mariette, X. and Nocturne, G. (2021) New 2019 SLE EULAR/ACR Classification Criteria Are Valuable for Distinguishing Patients with SLE from Patients with pSS. Annals of the Rheumatic Diseases, 80, e122. [Google Scholar] [CrossRef] [PubMed]
[3] Medlin, J.L., Hansen, K.E., McCoy, S.S. and Bartels, C.M. (2018) Pulmonary Manifestations in Late versus Early Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. Seminars in Arthritis and Rheumatism, 48, 198-204. [Google Scholar] [CrossRef] [PubMed]
[4] Piga, M., Tselios, K., Viveiros, L., Chessa, E., Neves, A., Urowitz, M.B., et al. (2023) Clinical Patterns of Disease: From Early Systemic Lupus Erythematosus to Late-Onset Disease. Best Practice & Research Clinical Rheumatology, 37, Article ID: 101938. [Google Scholar] [CrossRef] [PubMed]
[5] Celińska-Löwenhoff, M. and Musiał, J. (2015) Late-Onset Systemic Lupus Erythematosus: Clinical Manifestations, Course, and Prognosis. Polish Archives of Internal Medicine, 125, 497-499. [Google Scholar] [CrossRef
[6] Sakurai, N., Yoshimi, R. and Nakajima, H. (2025) Characteristics of Late-Onset Systemic Lupus Erythematosus: Clinical Manifestations and Diagnostic and Treatment Challenges. Drugs & Aging, 42, 1001-1009. [Google Scholar] [CrossRef
[7] Viveiros, L., Neves, A., Gouveia, T. and Isenberg, D.A. (2023) A Large Cohort Comparison of Very Late-Onset Systemic Lupus Erythematosus with Younger-Onset Patients. Clinical and Experimental Rheumatology, 42, 1480-1486. [Google Scholar] [CrossRef] [PubMed]
[8] 田玉, 杨玉淑, 丁萌, 等. 老年系统性红斑狼疮的临床特征及诊疗[J]. 中国老年学杂志, 2022, 42(9): 2187-2190.
[9] Jonsson, H., Nived, O. and Sturfelt, G. (1988) The Effect of Age on Clinical and Serological Manifestations in Unselected Patients with Systemic Lupus Erythematosus. The Journal of Rheumatology, 15, 505-509.
[10] 王许娜, 李楠, 王永峰, 等. 老年与非老年起病系统性红斑狼疮患者临床特点的比较[J]. 中国老年保健医学, 2022, 20(5): 94-96.
[11] Hopia, L., Andersson, M., Svenungsson, E., Khademi, M., Piehl, F. and Tomson, T. (2019) Epilepsy in Systemic Lupus Erythematosus: Prevalence and Risk Factors. European Journal of Neurology, 27, 297-307. [Google Scholar] [CrossRef] [PubMed]
[12] Liu, Y., Tu, Z., Zhang, X., Du, K., Xie, Z. and Lin, Z. (2022) Pathogenesis and Treatment of Neuropsychiatric Systemic Lupus Erythematosus: A Review. Frontiers in Cell and Developmental Biology, 10, Article ID: 998328. [Google Scholar] [CrossRef] [PubMed]
[13] Syed, A., Shaik, S., Afshan, R., Karam, A., Hafeez, W. and Almansour, S. (2024) Neuropsychiatric Systemic Lupus Erythematosus (NPSLE): A Case Report and an Overview of the Diagnosis, Treatment Modalities, and Prognosis. Cureus, 16, e65593. [Google Scholar] [CrossRef] [PubMed]
[14] Justiz-Vaillant, A.A., Gopaul, D., Soodeen, S., Arozarena-Fundora, R., Barbosa, O.A., Unakal, C., et al. (2024) Neuropsychiatric Systemic Lupus Erythematosus: Molecules Involved in Its Imunopathogenesis, Clinical Features, and Treatment. Molecules, 29, Article No. 747. [Google Scholar] [CrossRef] [PubMed]
[15] Bialas, A.R., Presumey, J., Das, A., van der Poel, C.E., Lapchak, P.H., Mesin, L., et al. (2020) Retraction Note: Microglia-Dependent Synapse Loss in Type I Interferon-Mediated Lupus. Nature, 578, Article No. 177. [Google Scholar] [CrossRef] [PubMed]
[16] 李世军. 弥漫性肺泡出血与自身免疫性疾病[J]. 肾脏病与透析肾移植杂志, 2003(5): 455-458.
[17] Merola, J., Bermas, B., Lu, B., Karlson, E., Massarotti, E., Schur, P., et al. (2014) Clinical Manifestations and Survival among Adults with (SLE) According to Age at Diagnosis. Lupus, 23, 778-784. [Google Scholar] [CrossRef] [PubMed]
[18] Shin, J.I., Lee, K.H., Park, S., et al. (2022) Systemic Lupus Erythematosus and Lung Involvement: A Comprehensive Review. Journal of Clinical Medicine, 11, Article No. 6714.
[19] Sun, Y., Zhou, C., Zhao, J., Wang, Q., Xu, D., Zhang, S., et al. (2020) Systemic Lupus Erythematosus-Associated Diffuse Alveolar Hemorrhage: A Single-Center, Matched Case-Control Study in China. Lupus, 29, 795-803. [Google Scholar] [CrossRef] [PubMed]
[20] 吕婷婷, 冯媛, 张岩. 系统性红斑狼疮合并弥漫性肺泡出血患者临床特征分析[J]. 中华实用诊断与治疗杂志, 2021, 35(9): 930-933.
[21] Nasser, M. and Cottin, V. (2018) Alveolar Hemorrhage in Vasculitis (Primary and Secondary). Seminars in Respiratory and Critical Care Medicine, 39, 482-493. [Google Scholar] [CrossRef] [PubMed]
[22] Andrade, C., Mendonça, T., Farinha, F., Correia, J., Marinho, A., Almeida, I., et al. (2015) Alveolar Hemorrhage in Systemic Lupus Erythematosus: A Cohort Review. Lupus, 25, 75-80. [Google Scholar] [CrossRef] [PubMed]
[23] Merrill, J.T., Manzi, S., Aranow, C., Askenase, A., Bruce, I., Chakravarty, E., et al. (2018) Lupus Community Panel Proposals for Optimising Clinical Trials: 2018. Lupus Science & Medicine, 5, e000258. [Google Scholar] [CrossRef] [PubMed]
[24] 詹宇威, 凌光辉. SLE合并弥漫性肺泡出血3例临床分析并文献复习[J]. 新医学, 2019, 50(3): 211-215.
[25] Al-Adhoubi, N.K. and Bystrom, J. (2020) Systemic Lupus Erythematosus and Diffuse Alveolar Hemorrhage, Etiology and Novel Treatment Strategies. Lupus, 29, 355-363. [Google Scholar] [CrossRef] [PubMed]
[26] Virdi, R.P.S., Bashir, A., Shahzad, G., Iqbal, J. and Mejia, J.O. (2012) Diffuse Alveolar Hemorrhage: A Rare Life-Threatening Condition in Systemic Lupus Erythematosus. Case Reports in Pulmonology, 2012, Article ID: 836017. [Google Scholar] [CrossRef] [PubMed]
[27] Martínez-Martínez, M.U. and Abud-Mendoza, C. (2014) Hemorragia alveolar difusa en pacientes con lupus eritematoso sistémico. Manifestaciones clínicas, tratamiento y pronóstico. Reumatología Clínica, 10, 248-253. [Google Scholar] [CrossRef] [PubMed]
[28] Zamora, M.R., Warner, M.L., Tuder, R. and Schwarz, M.I. (1997) Diffuse Alveolar Hemorrhage and Systemic Lupus Erythematosus: Clinical Presentation, Histology, Survival, and Outcome. Medicine, 76, 192-202. [Google Scholar] [CrossRef] [PubMed]
[29] Bertsias, G.K., Ioannidis, J.P.A., Aringer, M., Bollen, E., Bombardieri, S., Bruce, I.N., et al. (2010) EULAR Recommendations for the Management of Systemic Lupus Erythematosus with Neuropsychiatric Manifestations: Report of a Task Force of the EULAR Standing Committee for Clinical Affairs. Annals of the Rheumatic Diseases, 69, 2074-2082. [Google Scholar] [CrossRef] [PubMed]
[30] Tomic-Lucic, A., Petrovic, R., Radak-Perovic, M., Milovanovic, D., Milovanovic, J., Zivanovic, S., et al. (2013) Late-Onset Systemic Lupus Erythematosus: Clinical Features, Course, and Prognosis. Clinical Rheumatology, 32, 1053-1058. [Google Scholar] [CrossRef] [PubMed]
[31] Badsha, H., Teh, C.L., Kong, K.O., Lian, T.Y. and Chng, H.H. (2004) Pulmonary Hemorrhage in Systemic Lupus Erythematosus. Seminars in Arthritis and Rheumatism, 33, 414-421. [Google Scholar] [CrossRef] [PubMed]